Alzheimer’s May Involve Modified Genes in Brain Cells

Click For Summary
SUMMARY

Research indicates that brain cells from Alzheimer's patients exhibit modifications in the amyloid precursor protein gene, including duplications, partial deletions, and sequence changes. These alterations can lead to multiple gene copies within single cells and are hypothesized to be influenced by a reverse transcriptase enzyme, which operates in a "sloppy" manner. Current treatments involving reverse transcriptase inhibitors require further investigation before application in Alzheimer's therapy. The discussion highlights the potential correlation between Alzheimer's prevalence and the use of antiretroviral drugs that inhibit reverse transcriptase.

PREREQUISITES
  • Understanding of amyloid precursor protein gene modifications
  • Knowledge of reverse transcriptase enzyme functions
  • Familiarity with Alzheimer's disease pathology
  • Awareness of antiretroviral drug mechanisms
NEXT STEPS
  • Investigate the role of reverse transcriptase in gene modifications related to Alzheimer's disease
  • Research the effects of antiretroviral drugs on Alzheimer's disease prevalence
  • Examine the relationship between HIV-associated neurocognitive disorder (HAND) and Alzheimer's symptoms
  • Explore data mining techniques for analyzing electronic health records in Alzheimer's research
USEFUL FOR

Researchers, neurologists, geneticists, and healthcare professionals interested in Alzheimer's disease mechanisms and potential therapeutic avenues involving reverse transcriptase inhibitors.

BillTre
Science Advisor
Gold Member
Messages
2,739
Reaction score
11,968
Brain cells from Alzheimer's patients have been found to have modifications of the amyloid precursor protein gene which forms plaques in the brains of people with Alzheimer’s disease.
The modifications were duplications, partial deletions, and changes in sequence. This can result in multiple copies of the gene in single cells.
These changes have not (yet) been found in other organs or other genes.

This has been described as reminiscent of somatic recombination involved in generating antibody gene diversity, but in this case has been hypothesized to be due to a reverse transcriptase enzyme (makes DNA from RNA, but in a "sloppy" manner).
There are drugs that inhibit reverse transciptase, but more info would be needed before they would be used for any treatment.

Science magazine news story here.
Nature paper behind paywall here.
 
Biology news on Phys.org
Given the authors' hypothesis that reverse transcription is required for the DNA transposition effects, It would be interesting to look at the prevalence of Alzheimer's disease in patients taking antiretroviral drugs that inhibit reverse transcriptase (e.g. those taking anti-HIV drugs). Perhaps the answer to this question is already out there, and all it takes is some data mining of electronic health records. Once complicating factor, however, is the fact that many people with HIV infections often exhibit HIV-associated neurocognative disorder (HAND), which involves dementia-like symptoms similar to Alzheimer's.

Alternatively, perhaps the DNA transposition events are a beneficial response to the underlying pathology causing dementia, and perhaps inhibition of this response by antiretroviral drugs is causative of HAND. Definitely some very interesting directions for future research.
 

Similar threads

  • · Replies 2 ·
Replies
2
Views
5K
  • · Replies 2 ·
Replies
2
Views
3K
  • · Replies 1 ·
Replies
1
Views
2K
  • · Replies 3 ·
Replies
3
Views
6K
  • · Replies 8 ·
Replies
8
Views
4K
  • · Replies 5 ·
Replies
5
Views
3K
  • · Replies 32 ·
2
Replies
32
Views
7K